Macrophage migration inhibitory factor inhibits osteoclastogenesis

Bone

Volumn 45, Issue 4, 2009, Pages 640-649

  Jacquin, Claire ^a   Koczon Jaremko, Boguslawa ^a   Aguila, Hector L ^a   Leng, Lin ^b   Bucala, Richard ^b   Kuchel, George A ^a   Lee, Sun Kyeong ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

Bone marrow; Bone mass; Cytokine; Macrophage migration inhibitory factor; Osteoclast

Indexed keywords

COLECALCIFEROL; COLONY STIMULATING FACTOR 1; MACROPHAGE MIGRATION INHIBITION FACTOR; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; BONE MASS; BONE TURNOVER; CELL FUSION; CONTROLLED STUDY; EXON; FLOW CYTOMETRY; IN VITRO STUDY; INTRON; MALE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PROTEIN FUNCTION; TRABECULAR BONE;

ANIMALS; B-LYMPHOCYTES; BIOLOGICAL MARKERS; BONE MARROW CELLS; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOCALCIN; OSTEOCLASTS; OSTEOGENESIS; OSTEOPROTEGERIN; RANK LIGAND; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; X-RAY MICROTOMOGRAPHY;

EID: 68849093368     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.06.028     Document Type: Article

References (37)

1. Bloom B., and Bennet B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153 (1966) 80-82
2. David J. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Natl. Acad. Sci. U. S. A. 56 (1966) 72-77
3. Churchill W., Piessens W.F., Sulis C.A., and David J.R. Macrophage activated as suspension cultures with lymphocyte mediators devoid of antigen become cytotoxic for tumor cells. J. Immunol. 115 (1975) 781-786
4. Nathan C., Karnovsky M.L., and David J.R. Alterations of macrophage functions by mediators from lymphocytes. J. Exp. Med. 133 (1971) 1356-1376
5. Nathan C., Remold H.G., and David J.R. Characterization of a lymphocyte factor which alters macrophage functions. J. Exp. Med. 137 (1973) 275-290
6. Nishihira J., Koyama Y., and Mizue Y. Identification of macrophage migration inhibitory factor in human vascular endothelial cells and its induction by lipopolysaccharide. Cytokine 10 (1998) 199-205
7. Abe R., Shimizu T., Ohkawara A., and Nishihira J. Enhancement of macrophage migration inhibitory factor (MIF) expression in injured epidermis and cultured fibroblasts. Biochim. Biophys. Acta 1500 (2000) 1-9
8. Bernhagen J., Calandra T., Mitchell R.A., Martin S.B., Tracey K.J., Voelter W., et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature (1993) 365
9. Onodera S., Suzuki K., Matsuno T., Kaneda K., Kuriyama T., and Nishihira J. Identification of macrophage migration inhibitory factor in murine neonatal calvariae and osteoblasts. Immunology 89 (1996) 430-435
10. Onodera S., Nishihira J., Iwabuchi K., Koyama Y., Yoshida K., Tanaka S., et al. Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and -13 in rat osteoblasts. Relevance to intracellular signaling pathways. J. Biol. Chem. 277 (2002) 7865-7874
11. Onodera S., Nishihira J., Yamazaki M., Ishibashi T., and Minami A. Increased expression of macrophage migration inhibitory factor during fracture healing in rats. Histochem. Cell. Biol. 121 (2004) 209-217
12. Oshima S., Onodera S., Amizuka N., Li M., Irie K., Watanabe S., et al. Macrophage migration inhibitory factor-deficient mice are resistant to ovariectomy-induced bone loss. FEBS Lett. 580 (2006) 1251-1256
13. Onodera S., Oshima S., Nishihira J., Yasuda K., Tohyama H., Irie K., et al. Active immunization against macrophage migration inhibitory factor using a novel DNA vaccine prevents ovariectomy-induced bone loss in mice. Vaccine 26 (2008) 829-836
14. Mitchell R., Bacher M., Bernhagen J., Pushkarskaya T., Seldin M.F., and Bucala R. Cloning and characterization of the gene for mouse macrophage migration inhibitory factor (MIF). J. Immunol. 154 (1995) 3863-3870
15. Cao W., Morin M., Metz C., Maheux R., and Akoum A. Stimulation of macrophage migration inhibitory factor expression in endometrial stromal cells by interleukin 1, beta involving the nuclear transcription factor NFkappaB. Biol. Reprod. 73 (2005) 565-570
16. Onodera S., Sasaki S., Ohshima S., Amizuka N., Li M., Udagawa N., et al. Transgenic mice overexpressing macrophage migration inhibitory factor (MIF) exhibit high-turnover osteoporosis. J. Bone Miner. Res. 21 (2006) 876-885
17. Bozza M., Satoskar A.R., Lin G., Lu B., Humbles A.A., Gerard C., et al. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J. Exp. Med. 189 (1999) 341-346
18. Udagawa N., Takahashi N., Akatsu T., Sasaki T., Yamaguchi A., Kodama H., et al. The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology 125 (1989) 1805-1813
19. Lee S., and Lorenzo J.A. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. Endocrinology 140 (1999) 3552-3561
20. Akatsu T., Tamura T., Takahashi N., Udagawa N., Tanaka S., Sasaki T., et al. Preparation and characterization of a mouse osteoclast-like multinucleated cell population. J. Bone Miner. Res. 7 (1992) 1297-1306
21. Akatsu T., Takahashi N., Debari K., Morita I., Nagata N., Takatani O., et al. Prostaglandins promote osteoclast-like cell formation by a mechanism involving cyclic adenosine 3′,5′-monophosphate in mouse bone marrow cell cultures. J. Bone Miner. Res. 4 (1989) 29-35
22. Shuto T., Kukita T., Hirata M., Jimi E., and Koga T. Dexamethasone stimulates osteoclast-like cell formation by inhibiting granulocyte-macrophage colony-stimulating factor production in mouse bone marrow cultures. Endocrinology 134 (1994) 1121-1126
23. Katavić V., Grčević D., Lee S.K., Jastrzebski S., Dougall W., Anderson D., et al. The surface antigen CD45R identifies a population of estrogen-regulated murine marrow cells that contain osteoclast precursors. Bone 32 (2003) 581-590
24. Takahashi N., Yamana H., Yoshiki S., Roodman G.D., Mundy G.R., Jones S.J., et al. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology 122 (1988) 1373-1382
25. Lee S.K., Goldring S.R., and Lorenzo J.A. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin. Endocrinology 136 (1995) 4572-4581
26. Menaa C., Kurihara N., and Roodman G.D. CFU-GM-derived cells form osteoclasts at a very high efficiency. Biochem. Biophys. Res. Commun. 267 (2000) 943-946
27. Chirgwin J., Przybyla A.E., MacDonald R.J., and Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18 (1979) 5294-5299
28. Parfitt A.M., Drezner M.K., Vlorieux F.H., Kanis J.A., Malluche H., Meunier P.J., et al. Bone histomorphometry: stardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2 (1987) 595-610
29. Jacquin C., Gran D.E., and Lee S.K. Lorenzo, Aguila HL. Identification of multiple osteoclast precursor populations in murine bone marrow. J. Bone Miner. Res. 21 (2006) 67-77
30. Honma N., Koseki H., Akasaka T., Nakayama T., Taniguchi M., Serizawa I., et al. Deficiency of the macrophage migration inhibitory factor gene has no significant effect on endotoxaemia. Immunology 100 (2000) 84-90
31. Min-induced intestinal neoplasia. Cell 81 (1995) 957-966
32. Fleming R., Holden C.C., Tomatsu S., Waheed A., Brunt E.M., Britton R.S., et al. Mouse strain differences determine severity of iron accumulation in Hfe knockout model of hereditary hemochromatosis. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 2702-2711
33. Dobkin C., Rabe A., Dumas R., El Idrissi A., Haubenstock H., and Brown W.T. Fmr1 knockout mouse has a distinctive strain-specific learning impairment. Neuroscience 100 (2000) 429-432
34. Paradee W., Melikian H.E., Rasmussen D.L., Kenneson A., Conn P.J., and Warren S.T. Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function. Neuroscience 94 (1999) 185-192
35. Threadgill D., Dlugosz A.A., Hansen L.A., Tennenbaum T., Ulrike L., Yee D., et al. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269 (1995) 230-234
36. Onodera S., Nishihira J., Koyama Y., Majima T., Aoki Y., Ichiyama H., et al. Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1β. Arthritis Rheum. 50 (2004) 1437-1447
37. Ichiyama H., Onodera S., Nishihira J., Ishibashi T., Nakayama T., Minami A., et al. Inhibition of joint inflammation and destruction induced by anti-type II collagen antibody/lipopolysaccharide (LPS)-induced arthritis in mice due to deletion of macrophage migration inhibitory factor (MIF). Cytokine 26 (2004) 187-194